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Abstract Somatostatin (SST) inhibits the secretion of many
peptide hormones including growth hormone (GH). The various
functions of SST are mediated through at least five different
receptor subtypes (SSTR1^5), their precise physiological roles
have not been solved yet. Here we report on studies concerning
the functional role of SSTR1 in the modulation of GH release
from somatotrophs. Primary cell cultures from pituitaries of
wild-type SSTR1 mice exposed to the SSTR1 selective
somatostatin analog CH-275 show reduction of basal levels of
GH secretion whereas somatotrophs isolated from SSTR1 null
mutant mice did not respond to the agonist-mediated effect. This
suggests that SSTR1 is involved in modulating basal GH levels in
primary pituitary cell cultures and, together with SSTR2, may
control the secretion of GH in the body.
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1. Introduction
The neuropeptide somatostatin regulates the release of
many hormones and neurotransmitters in multiple tissues
such as the brain, pituitary and the pancreas. The actions of
somatostatin are mediated by ¢ve di¡erent seven transmem-
brane somatostatin receptors (SSTR1^5) which are all
coupled to pertussis-toxin sensitive G-proteins of the Gi/Go
type [1]. Due to the overlapping tissue distribution of SSTRs
[2] and the limited availability of subtype-speci¢c agonists or
antagonists, it has been unclear so far which of the e¡ects of
somatostatin and its recently discovered homolog cortistatin
are mediated by which receptor subtype. The only receptor of
which the function is understood in some detail is SSTR2,
because several subtype speci¢c agonists as well as antagonists
are available [3]; in addition a knock out (ko) mouse for this
subtype has been generated [4,5]. Taken together, the data
from these experiments indicate that SSTR2 is involved in
the regulation of gastric acid secretion, some aspects of pan-
creatic hormone release and the hypothalamic control of
growth hormone (GH) release.
The situation is far less clear for the other subtypes includ-
ing SSTR1. This subtype is widely expressed in brain, but
occurs also in peripheral tissues such as the gut [6]. Its possi-
ble contribution in the release inhibition actions of somato-
statin in the pituitary has been proposed [7]. Here we show by
comparing somatotrophs derived from SSTR1 (+/+) and
SSTR1 (3/3) mice that the basal level of GH release is under
the control of SSTR1.
2. Materials and methods
2.1. Analysis of GH release from primary cultured mouse pituitary cells
The pituitaries of 15 mice (C57BL/6) were prepared, sliced and
incubated in 30 ml of dispersion bu¡er (3 mg/ml collagenase II (200
U/mg, Worthington, St. Katharinen, Germany) in 1UHanks’ bal-
anced salt solution (Seromed, Berlin, Germany, 10 mM D-glucose,
10 mM HEPES, pH 7.4, 0.5 mg/ml bovine serum albumin (BSA)
fraction V) at 37‡C for 45 min with vigorous shaking by hand every
15 min. The resulting tissue pieces were pelleted by centrifugation
(5 min, 200Ug) and dispersed in 3 ml of a trypsin solution (0.05%
trypsin, 0.5 mM EDTA in phosphate bu¡ered saline (PBS)) by up and
down pipetting using a Pasteur pipette. The incubation with trypsin
was stopped by addition of 3 ml of Dulbecco’s modi¢ed Eagle me-
dium (DMEM) medium (3.7 mg/ml NaHCO3, 1 mg/ml D-glucose,
15 Wg/ml phenol red, Seromed, Berlin, Germany) containing 0.1%
BSA fraction V. Cells were pelleted by centrifugation (200Ug), resus-
pended in 2 ml of DMEM/BSA and 105 cells were seeded per well of a
polylysine (Sigma, Deisenhofen, Germany) coated 24 well plate. 1.5^
2U106 cells were routinely obtained. When the cells were settled the
DMEM/BSA medium was replaced by DMEM medium containing
10% fetal bovine serum, 2 mM glutamine, 50 U/ml Penicillin and
50 ng/ml Streptomycin. The cells were maintained 4 days at 37‡C in
a humidi¢ed 5% CO2/95% air atmosphere and the medium was ex-
changed every 2 days. Before testing various compounds for their
ability to inhibit GH release, cells were washed twice, 2 h and imme-
diately before the experiment with the culture medium containing
25 mM HEPES, pH 7.4. Experiments were conducted in triplicates.
For the analysis of inhibition of basal GH release the somatostatin
peptides were applied in 1 ml of fresh medium to each well. After
incubation for 3 h under cell culture conditions the medium was
collected and analyzed for the concentration of GH using a double
antibody radioimmunoassay protocol (Amersham-Pharmacia, Frei-
burg, Germany). For analysis of inhibition of forskolin-stimulated
GH release cells were washed twice with culture medium lacking phe-
nol red and incubated with forskolin (1 WM) for 3 h in the absence or
presence of peptides.
2.2. Null mutation
By screening a 129sv genomic library (VFixIIDash, Stratagene, La
Jolla, CA, USA) a genomic clone containing the mouse sstr1 gene was
obtained containing 8 kb of genomic DNA encompassing 2.5 kb up-
stream and 4.0 kb downstream of the coding sequence. From this
region, a targeting vector was constructed in which the entire
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SSTR1 coding sequence was replaced by the neomycin resistance gene
(Fig. 1A). Fragments containing either 5P or 3P £anking regions of the
SSTR1 gene were subcloned into pBluescript; the identity of the in-
serts was con¢rmed by DNA sequencing. The 5P and 3P £anking
regions of the SSTR1 gene were then cloned into the vector pPNT
to obtain the SSTR1ko targeting vector. The vector was linearized
using the NotI restriction enzyme, and transfected into J1 embryonic
stem (ES) cells by electroporation (pPNT vector and stem cells were
kindly provided by Dr. R. Jaenisch, Boston, MA, USA). ES cells were
positively selected for the neomycin resistance gene with G418 and
negatively with Gancyclovir. Individual clones were isolated, ex-
panded and duplicated. ES cells were grown on mitotically inactivated
primary ¢broblasts. 500 clones were selected and screened for correct
insertion of the transgene by Southern blot analysis of genomic DNA
digested with XhoI (Fig. 1B). Filter hybridization was performed with
a K-32P-labelled probe consisting of 5P-£anking sequence of 500 bp
(XhoI/HindIII fragment; see Fig. 1) yielding a 3.5 kb fragment wild-
type (wt) or 4.2 kb fragment (ko) by using standard protocols [8]. A
total of 15 clones with a deletion of one SSTR1 allele could be ob-
tained. Two clones, #5 and #9 were used for injection into blastocysts
of C57BL/6 mice. Custom injections were performed at BRL Biolog-
ical Research Laboratories, Fu«llinsdorf, Switzerland. These animals
were crossed back into a C57BL/6 background. Only one of these
animals gave rise to germ line transmission of the desired transgene
as analyzed by coat color and Southern hybridization analysis of tail
biopsies.
SSTR1 null mutant mice were reared in the animal facility up to an
age of 18 months without any apparent abnormalities. They repro-
duced normally with litter sizes of 6 to 10 animals. When homozygous
(3/3) animals were compared with their wt littermates, no obvious
abnormalities were detected; i.e. no signi¢cant di¡erences in the body
weight of adult animals were observed. Upon dissection of adult ani-
mals internal organs were found in normal size and shape.
3. Results and discussion
The major action of somatostatin, inhibition of GH release
from pituitary somatotrophs has been attributed to SSTR2 [9]
although all SSTR subtypes are present in the hypophysis and
even in individual pituitary cells [2]. Recently, it has been
shown that the SSTR1 speci¢c somatostatin-14 (SST-14) ana-
logue [des-Ala1, des-Gly2, des-Asn5, D-Trp8, IAmp9] SST-14
(CH-275) mediates the inhibition of voltage-operated calcium
channels suggesting that SSTR1 may well be engaged in the
inhibition of hormone release [7]. In accordance with this ob-
servation Table 1 shows that the SSTR1 selective agonist CH-
275 mediates the inhibition of basal GH release (25 þ 5%)
although at a smaller extent than SST-14 (51 þ 7%) and the
SSTR2/SSTR5 selective agonist octreotide (47 þ 4%). This
may be due to di¡erent levels of binding sites for each ligand
present on somatotrophs. The SSTR1 selective compound
CH-275 does not a¡ect the forskolin-stimulated GH release
while the SSTR2/SSTR5 selective agonist octreotide and SST-
14 are very e¡ective.
In order to study the precise contribution of SSTR1 in the
inhibitory process of basal GH release somatotrophs were
cultured from pituitaries of SSTR1 null mutant mice (Fig.
2). Homozygous SSTR1 (3/3) mice were obtained by cross-
Fig. 1. Strategy for targeting the SSTR1 gene. A: The upper row shows the mouse wt SSTR1 locus used for construction of the targeting vec-
tor (tv) in which the SSTR1 coding region was replaced with a neomycin cassette in reverse orientation (middle row). The herpes simplex virus
thymidine kinase (HSV tk) gene was inserted for negative selection. The bottom line shows the ¢nal orientation of the targeting cassette in the
mutant sstr1 locus. Restriction sites are depicted as B (BamHI); E (EcoRI), H (HindIII), S (Sal), X (XhoI), and N (NotI). B: Southern blot
analysis using genomic DNA derived from ES cell clones. DNA was digested with XhoI, and the XhoI^HindIII fragment depicted in A was
used as a probe for hybridization. According to (A) the wt allele yields a band of 3.5 kb and the targeted allele of 4.2 kb in size. Left lane,
positive ES cell clone showing both alleles; right lane, control ES cells.
Table 1
Growth hormone release
Somatotrophs SSTR1 mediated basal GH release (%)
forskolin
3 +
Somatotrophs 100 240
+SST-14 49 65
+CH-275 75 275
+Octreotide 53 70
Primary pituitary cells were prepared from mice and incubated in
the absence (3) or presence of 1 WM forskolin (+) and with 0.5 WM
of SST-14, CH-275 (Neosystem, Strasbourg, France) or octreotide.
The basal GH release of 4.85 þ 0.65 ng GH per 100 Wl medium and
1U105 cells was set as 100%.
Fig. 2. SSTR1 mediates inhibition of basal GH release. Primary
pituitary cells were prepared from SSTR1 (3/3) (black bars) and
(+/+) (gray bars) mice and incubated in the presence of 0.5 WM of
CH-275, (Neosystem, Strasbourg, France), octreotide or SST-14.
Each experiment was performed twice in triplicate. The basal GH
release of 4.85 þ 0.65 and 7.85 þ 0.35 ng GH per 100 Wl medium and
1U105 cells was set as 100% for pituitary cells from SSTR1 (+/+)
and SSTR1 (3/3) mice, respectively. *; P6 0.01, **; P6 0.02.
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ing heterozygous SSTR1 ( þ ) mice yielding o¡-springs with
SSTR1 (+/+), SSTR1 ( þ ) and SSTR1 (3/3) mice at the ex-
pected Mendelian ratios. Absence of the transgene in SSTR1
null mutants was con¢rmed by RT-PCR (Fig. 3A) and North-
ern blot analysis (Fig. 3B) of RNA isolated from the brains of
SSTR1 (3/3) and SSTR1 (+/+) mice using primers directed
at either the 5P- or the 3P-part of the coding region. The
possibility that the lack of the SSTR1 gene could be compen-
sated by an upregulated expression of one of the other SSTRs
was excluded by Northern blot analysis (data not shown).
Somatotrophs from SSTR1 (3/3) mice were not sensitive
to CH-275 suggesting that SSTR1 needs to be present to
mediate the inhibition of GH release by CH-275 (Fig. 2).
The contribution of SSTR1 to the inhibition of basal GH
release is also re£ected by an increased basal concentration
of GH in the culture medium of pituitary cells from SSTR1
(3/3) mice. Moreover, a smaller e¡ect of SST-14 to reduce
basal GH release from somatotrophs of SSTR1 (3/3) mice
compared to wt animals was also observed. In contrast, the
e¡ect of octreotide is not diminished. As expected, CH-275
does not a¡ect the forskolin-stimulated GH release neither in
pituitary cells derived from SSTR1 (+/+) nor from SSTR1 (3/
3) mice (data not shown) while the SSTR2/SSTR5 selective
agonist octreotide and SST-14 are very e¡ective (Table 1).
In conclusion, the data reported here strongly support the
notion that expression of the SSTR1 gene is essential in the
regulation of basal levels of GH in mice. Mice lacking a func-
tional SSTR1 gene are unable to modulate these basal GH
levels in primary pituitary cell cultures. This may point to a
more complex role of the SST receptor subtypes in growth
control which may include not only SSTR2 but also SSTR1.
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Fig. 3. RT-PCR and Northern blot analysis of SSTR1 gene expres-
sion. A: Total RNA was isolated from adult mouse brains, and
used for RT-PCR analysis using primers recognizing a cDNA frag-
ment encompassing the SSTR1 N-terminus [2]: forward primer, 5P-
GCCGCACCGGCCCACTTC (bp 63^80 of the mouse SSTR1
gene; accession number M81831, GenBank database); reverse prim-
er, 5P-GTAGCGCGCCGAAGGGCC (bp 472^455 of the mouse
SSTR1 gene). Actin speci¢c primers were used in a control reaction.
Predicted fragment sizes are 450 bp for the SSTR1 reaction and
600 bp for actin. A similar result was obtained with primer sets spe-
ci¢cally recognizing the SSTR1 C-terminus (not shown). Left lane,
marker (VEcoRI/HindIII). B: Northern blot analysis of poly (A)
RNA from brains of SSTR1 (+/+) and SSTR1 (3/3) mice. 5 Wg
poly (A) RNA was separated on 1% agarose gels in 40 mM mor-
pholinopropane sulfonic acid, 10 mM sodium acetate, 6.6% formal-
dehyde. After electrophoresis RNA was transferred to nylon ¢lters
(Hybond N, Amersham, Braunschweig, Germany) and UV cross-
linked to the membrane. Filters were hybridized at 50‡C in 5USSC,
10U Denhardt’s solution, 100 Wg/ml denatured salmon sperm DNA,
0.1% SDS, 50% formamide for 16 h. Blots were washed twice in
2USSC/0.1% SDS for 5 min at room temperature and twice at
55‡C for 15 min. Exposure of the ¢lters to X-ray ¢lms was for 96 h
at 380‡C. Hybridization with a glycerine aldehyde phospho dehy-
drogenase (GAPDH) probe was performed as a control experiment.
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